Phase 3 Trial of Concizumab in Hemophilia with Inhibitors.

Matsushita T, Shapiro A, Abraham A, Angchaisuksiri P, Castaman G, Cepo K, d'Oiron R, Frei-Jones M, Goh AS, Haaning J, Hald Jacobsen S, Mahlangu J, Mathias M, Nogami K, Skovgaard Rasmussen J, Stasyshyn O, Tran H, Vilchevska K, Villarreal Martinez L, Windyga J, You CW, Zozulya N, Zulfikar B, Jiménez-Yuste V, explorer7 Investigators.

Open source

DOI: 10.1056/nejmoa2216455
Published: 2023-08-01
Container: N Engl J Med
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2216455,
  title = {Phase 3 Trial of Concizumab in Hemophilia with Inhibitors.},
  author = {Matsushita T and  Shapiro A and  Abraham A and  Angchaisuksiri P and  Castaman G and  Cepo K and  d'Oiron R and  Frei-Jones M and  Goh AS and  Haaning J and  Hald Jacobsen S and  Mahlangu J and  Mathias M and  Nogami K and  Skovgaard Rasmussen J and  Stasyshyn O and  Tran H and  Vilchevska K and  Villarreal Martinez L and  Windyga J and  You CW and  Zozulya N and  Zulfikar B and  Jiménez-Yuste V and  explorer7 Investigators.},
  year = {2023},
  journal = {N Engl J Med},
  doi = {10.1056/nejmoa2216455},
  url = {https://doi.org/10.1056/nejmoa2216455}
}

RIS

TY  - JOUR
TI  - Phase 3 Trial of Concizumab in Hemophilia with Inhibitors.
AU  - Matsushita T
AU  -  Shapiro A
AU  -  Abraham A
AU  -  Angchaisuksiri P
AU  -  Castaman G
AU  -  Cepo K
AU  -  d'Oiron R
AU  -  Frei-Jones M
AU  -  Goh AS
AU  -  Haaning J
AU  -  Hald Jacobsen S
AU  -  Mahlangu J
AU  -  Mathias M
AU  -  Nogami K
AU  -  Skovgaard Rasmussen J
AU  -  Stasyshyn O
AU  -  Tran H
AU  -  Vilchevska K
AU  -  Villarreal Martinez L
AU  -  Windyga J
AU  -  You CW
AU  -  Zozulya N
AU  -  Zulfikar B
AU  -  Jiménez-Yuste V
AU  -  explorer7 Investigators.
PY  - 2023
JO  - N Engl J Med
DO  - 10.1056/nejmoa2216455
UR  - https://doi.org/10.1056/nejmoa2216455
ER  -

APA

T, M., A, S., A, A., P, A., G, C., K, C., R, D., M, F., AS, G., J, H., S, H. J., J, M., M, M., K, N., J, S. R., O, S., H, T., K, V., L, V. M., J, W., CW, Y., N, Z., B, Z., V, J., & Investigators., E. (2023). Phase 3 Trial of Concizumab in Hemophilia with Inhibitors.. N Engl J Med. https://doi.org/10.1056/nejmoa2216455

Source records

europe-pmc · retrieved 2026-09-27T00:08:12.769Z
hal · retrieved 2026-09-27T00:08:12.799Z